Maitri Enterprises Ltd
Incorporated in 1991, Maitri Enterprises Ltd is engaged in the business of Pharmaceutical products
- Market Cap ₹ 10.5 Cr.
- Current Price ₹ 23.9
- High / Low ₹ 51.3 / 18.7
- Stock P/E 30.0
- Book Value ₹ 12.1
- Dividend Yield 0.00 %
- ROCE 2.43 %
- ROE -9.48 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Company has high debtors of 169 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Diversified Industry: Diversified - Medium / Small
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|
4.55 | 19.92 | 13.26 | 18.93 | 29.08 | |
4.47 | 19.23 | 12.76 | 18.68 | 26.77 | |
Operating Profit | 0.08 | 0.69 | 0.50 | 0.25 | 2.31 |
OPM % | 1.76% | 3.46% | 3.77% | 1.32% | 7.94% |
0.09 | 0.06 | 0.11 | 0.13 | -0.92 | |
Interest | 0.02 | 0.32 | 0.37 | 0.73 | 1.09 |
Depreciation | 0.05 | 0.09 | 0.07 | 0.06 | 0.08 |
Profit before tax | 0.10 | 0.34 | 0.17 | -0.41 | 0.22 |
Tax % | 40.00% | 32.35% | 94.12% | 9.76% | |
0.07 | 0.23 | 0.00 | -0.45 | -0.27 | |
EPS in Rs | 0.37 | 0.52 | 0.00 | -1.02 | -0.62 |
Dividend Payout % | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 61% |
TTM: | 74% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 133% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | % |
3 Years: | -17% |
1 Year: | -24% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | -9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|
Equity Capital | 4.40 | 4.40 | 4.40 | 4.40 |
Reserves | 0.57 | 0.57 | 0.12 | 0.93 |
5.72 | 6.34 | 10.54 | 8.24 | |
6.85 | 7.09 | 6.61 | 6.37 | |
Total Liabilities | 17.54 | 18.40 | 21.67 | 19.94 |
0.28 | 0.24 | 0.24 | 0.25 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.27 | 0.27 | 3.92 | 3.73 |
16.99 | 17.89 | 17.51 | 15.96 | |
Total Assets | 17.54 | 18.40 | 21.67 | 19.94 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
-0.39 | 0.02 | 0.06 | ||
-3.27 | -0.24 | -3.45 | ||
3.69 | 0.24 | 3.49 | ||
Net Cash Flow | 0.03 | 0.02 | 0.10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Debtor Days | 163.81 | 205.62 | 168.71 | |
Inventory Days | 210.48 | 261.85 | 150.06 | |
Days Payable | 186.79 | 206.97 | 122.82 | |
Cash Conversion Cycle | 187.50 | 260.50 | 195.96 | |
Working Capital Days | 157.76 | 248.29 | 177.20 | |
ROCE % | 4.91% | 2.43% |
Documents
Announcements
-
Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2025 And To Consider Other Business Items, If Any
1d - Board meeting on May 30 to approve audited Q4 and annual results for FY 2024-25.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
8 May - Company Secretary Kirtan Panchal resigned effective May 2, 2025, disclosed as per SEBI regulations.
-
Appointment of Company Secretary and Compliance Officer
2 May - Appointment and resignation of Company Secretary; new Secretarial Auditor appointed for FY 2024-25.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
2 May - Appointment and resignation of Company Secretary; new Secretarial Auditor appointed for FY 2024-25.
-
Appointment Of Secretarial Auditor
2 May - Appointment and resignation of Company Secretary; new Secretarial Auditor appointed for FY 2024-25.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
a) Trading of Pharmaceutical & Medical Goods
b) Manufacturing of metal furniture
c) Trading of building materials